SCHEMBL2627552

SCHEMBL2627552

c1ccc(-n2c3ccc(-c4cn5ccccc5n4)cc3c3c4ccccc4c4ccc5ccccc5c4c32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 13/20 0.45
▸ GFER P55789 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ MIF P14174 1/20 0.45
▸ NPC1 O15118 11/20 0.43
▸ KDM4E B2RXH2 10/20 0.43
▸ SMN1; SMN2 Q16637 7/20 0.43
▸ ALDH1A1 P00352 7/20 0.43
▸ MAPT P10636 5/20 0.43
▸ HTT P42858 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ POLB P06746 3/20 0.42
▸ PKM P14618 4/20 0.42
▸ MAPK1 P28482 3/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627515 0.82 RAB9A (0.47) RAB9AGFERMEN1KMT2AGAA
SCHEMBL9888912 0.82 RAB9A (0.57) RAB9AGFERMEN1KMT2AGAA
SCHEMBL2627560 0.80 MEN1 (0.39) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL2627511 0.80 RAB9A (0.53) RAB9AGFERMEN1KMT2AGAA
SCHEMBL9889778 0.79 RAB9A (0.53) RAB9AGFERMEN1KMT2AGAA
SCHEMBL15126697 0.79 RAB9A (0.41) RAB9AGFERMEN1KMT2AGAA
SCHEMBL2627498 0.78 ALDH1A1 (0.37) MEN1KMT2AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL2627493 0.78 KDM4E (0.34) RAB9AMEN1KMT2ANPC1KDM4E
SCHEMBL15930288 0.78 RAB9A (0.52) RAB9AGFERMEN1KMT2AGAA
SCHEMBL2627564 0.78 AKT2 (0.40) RAB9AGAANPC1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9362506-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-07 — — US disclosed
US-9362506-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-07 — — US disclosed
US-20140291654-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2014-10-02 — — US disclosed
US-20140291654-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2014-10-02 — — US disclosed
US-8815417-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2014-08-26 — — US disclosed
US-8815417-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2014-08-26 — — US disclosed
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 — — US disclosed
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY2, CRY1, CCNE2 RAB9A 2330/4885GFER 2642/4885MEN1 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback